Cargando…

Mandatory pharmacist-led education session for patients seeking medical cannabis

OBJECTIVE: The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Parihar, Vikas, Katz, Laura, Siyam, Mahmoud A., Rogers, Anna, Patterson, Lisa, Zacharias., Ramesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732211/
https://www.ncbi.nlm.nih.gov/pubmed/33343771
http://dx.doi.org/10.18549/PharmPract.2020.4.2088
_version_ 1783622042500726784
author Parihar, Vikas
Katz, Laura
Siyam, Mahmoud A.
Rogers, Anna
Patterson, Lisa
Zacharias., Ramesh
author_facet Parihar, Vikas
Katz, Laura
Siyam, Mahmoud A.
Rogers, Anna
Patterson, Lisa
Zacharias., Ramesh
author_sort Parihar, Vikas
collection PubMed
description OBJECTIVE: The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis products and dosage forms for medical use among patients. METHODS: A retrospective analysis of completed pre-post session questionnaires was conducted among chronic pain patients attending a mandatory education session led by a pharmacist, prior to being authorized cannabis in clinic. All questionnaire data was analyzed using SPSS v. 25. Demographic and sample characteristics were reviewed using univariate analyses. Chi-Square tests were employed to determine if the group-based education significantly affected knowledge, perception of efficacy and safety of cannabis. RESULTS: Of the 260 session participants, 203 completed pre-post session questionnaires. After the session, a majority of current cannabis users (33.8%) and cannabis naïve/past users (56.9%) reported they would use a low THC product in the future, and a majority of current users (54.5%) would use a high CBD product in the future. After education, participants were more likely to report cannabis as having the potential for addiction (chi-square =42.6, p <0.0001) and harm (chi-square =34.0, p <0.0001). CONCLUSIONS: Pharmacist counselling and education has the potential to influence patient selection and use of cannabis, from more harmful to safer products, as well as moderate the potential perceived benefits of use.
format Online
Article
Text
id pubmed-7732211
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-77322112020-12-18 Mandatory pharmacist-led education session for patients seeking medical cannabis Parihar, Vikas Katz, Laura Siyam, Mahmoud A. Rogers, Anna Patterson, Lisa Zacharias., Ramesh Pharm Pract (Granada) Original Research OBJECTIVE: The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis products and dosage forms for medical use among patients. METHODS: A retrospective analysis of completed pre-post session questionnaires was conducted among chronic pain patients attending a mandatory education session led by a pharmacist, prior to being authorized cannabis in clinic. All questionnaire data was analyzed using SPSS v. 25. Demographic and sample characteristics were reviewed using univariate analyses. Chi-Square tests were employed to determine if the group-based education significantly affected knowledge, perception of efficacy and safety of cannabis. RESULTS: Of the 260 session participants, 203 completed pre-post session questionnaires. After the session, a majority of current cannabis users (33.8%) and cannabis naïve/past users (56.9%) reported they would use a low THC product in the future, and a majority of current users (54.5%) would use a high CBD product in the future. After education, participants were more likely to report cannabis as having the potential for addiction (chi-square =42.6, p <0.0001) and harm (chi-square =34.0, p <0.0001). CONCLUSIONS: Pharmacist counselling and education has the potential to influence patient selection and use of cannabis, from more harmful to safer products, as well as moderate the potential perceived benefits of use. Centro de Investigaciones y Publicaciones Farmaceuticas 2020 2020-11-30 /pmc/articles/PMC7732211/ /pubmed/33343771 http://dx.doi.org/10.18549/PharmPract.2020.4.2088 Text en Copyright: © Pharmacy Practice and the Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Parihar, Vikas
Katz, Laura
Siyam, Mahmoud A.
Rogers, Anna
Patterson, Lisa
Zacharias., Ramesh
Mandatory pharmacist-led education session for patients seeking medical cannabis
title Mandatory pharmacist-led education session for patients seeking medical cannabis
title_full Mandatory pharmacist-led education session for patients seeking medical cannabis
title_fullStr Mandatory pharmacist-led education session for patients seeking medical cannabis
title_full_unstemmed Mandatory pharmacist-led education session for patients seeking medical cannabis
title_short Mandatory pharmacist-led education session for patients seeking medical cannabis
title_sort mandatory pharmacist-led education session for patients seeking medical cannabis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732211/
https://www.ncbi.nlm.nih.gov/pubmed/33343771
http://dx.doi.org/10.18549/PharmPract.2020.4.2088
work_keys_str_mv AT pariharvikas mandatorypharmacistlededucationsessionforpatientsseekingmedicalcannabis
AT katzlaura mandatorypharmacistlededucationsessionforpatientsseekingmedicalcannabis
AT siyammahmouda mandatorypharmacistlededucationsessionforpatientsseekingmedicalcannabis
AT rogersanna mandatorypharmacistlededucationsessionforpatientsseekingmedicalcannabis
AT pattersonlisa mandatorypharmacistlededucationsessionforpatientsseekingmedicalcannabis
AT zachariasramesh mandatorypharmacistlededucationsessionforpatientsseekingmedicalcannabis